25 Biotechnology Companies
That Have Announced or signaled IPO plans
Track biotechnology companies that have announced or are rumored to be planning an IPO in real-time.
Download this list
25 companies, each with its dated signal
Get 4 rows free · IPO Bound Biotechnology Companies
The list's first rows in Excel, with every column the full file has and how full each one is. One e-mail, then at most two short notes.
Need it kept current? See how Signal Tracker works
Other Signals in Biotechnology:
This page lists 25 biotechnology companies that have announced or signaled IPO plans recently. Each company detected a ipo bound signal through Bounce Watch's real-time monitoring system that tracks 40+ growth and risk indicators across thousands of companies.
BlossomHill Therapeutics, Inc.
San Diego, United States (2020)
Addressing urgent unmet medical needs through deeper science, true originality, and rich experience...
Sandoz in Deutschland
Holzkirchen, Germany (1886)
Pioneering access for patients als weltweit führender Anbieter von patentfreien Arzneimitteln und Biosimi...
Insilico Medicine
Boston, United States (2014)
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLMS #AIDD
Parabilis Medicines
Cambridge, United States (2016)
We are dedicated to creating extraordinary medicines for people affected by serious diseases
AstraZeneca
Cambridge, United Kingdom (1913)
Biopharmaceutical solutions for major global diseases
Crescent Biopharma
Waltham, United States
Delivering the next wave of transformative therapies to bring a brighter future for people living with ca...
Palatin Technologies
(1986)
We discover and develop novel therapeutics for patients living with inflammatory and autoimmune condition...
Odyssey Therapeutics
(2021)
Building a machine learning-based platform to develop novel therapeutics focusing on cancer and autoimmun...
Hemab Therapeutics
Denmark (2020)
The next generation of therapeutics for bleeding and thrombotic disorders
Track IPO Bound Signals in Real-Time
Get instant alerts when biotechnology companies show ipo bound activity. Monitor 40+ signal types across your target market.
Book a demo
Senti Biosciences
South San Francisco, United States (2016)
Outsmarting complex diseases with more intelligent medicines
Avalo Therapeutics
Rockville, United States (2011)
Innovation driven by compassion.
Seaport Therapeutics
Boston, United States (2024)
We are a clinical-stage therapeutics company advancing the development of novel neuropsychiatric medicine...
Mabwell
Shanghai, China (2017)
Explore Life, Benefit Health
ALPS Group Inc.
Malaysia (2017)
The ALPS Group Inc. (ALPS) Group of companies, is a fully-integrated biotechnology research, medical and...
BillionToOne
Menlo Park, United States (2016)
We push the boundaries of molecular diagnostics through quantitative technologies.
Korsana Biosciences
Waltham, United States (2024)
Therapeutics for neurodegenerative diseases targeting amyloid beta
Immunocore
Abingdon, United Kingdom (2008)
Science to Transform Lives
Generate:Biomedicines
Somerville, United States (2018)
Pioneering generative biology to create breakthrough therapeutics.
Agomab
Belgium (2017)
Unlocking Disease Modification in Fibro-Inflammation
Eikon Therapeutics
Millbrae, United States (2019)
Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and developing breakthrou...
Cullinan Therapeutics
Cambridge, United States (2016)
Science That Moves
Alumis
South San Francisco, United States (2021)
Transforming the lives of patients living with immune-mediated diseases using a precision approach.
Aardvark Therapeutics
San Diego, United States (2017)
Rethinking Metabolic Health
Alto Neuroscience
Mountain View, United States (2019)
Precision medicine for the brain is here.
Evommune
Palo Alto, United States (2020)
Developing innovative therapies that target key drivers of chronic inflammatory diseases.
What changed at these Biotechnology companies recently?
We recorded 87 changes here in the last 180 days, including 17 funding events, 16 product launches, 16 awards, 15 milestones and 14 traction updates. Each entry below carries the date we observed it, from public sources.
-
Insilico Medicine
— Growth Metrics Shared
-
Odyssey Therapeutics
— Key Hire Announced
-
AstraZeneca
— New Office Opened
-
Crescent Biopharma
— Regulatory Approval
-
Generate:Biomedicines
— New Product Launched
-
Immunocore
— Growth Metrics Shared
-
BlossomHill Therapeutics, Inc.
— IPO Announced
-
Sandoz in Deutschland
— IPO Announced
